Phibro (PAHC) Form 4: Lisa Escudero receives 2,152 RSUs with 3-year vesting

Rhea-AI Filing Summary

Insider grant of restricted stock units to a senior officer at Phibro Animal Health (PAHC). Lisa Ann Escudero, Senior Vice President, Human Resources, was awarded 2,152 restricted stock units (RSUs) on 08/15/2025. Each RSU represents the contingent right to receive one share of Class A Common Stock and was reported with a transaction code indicating a grant at $0. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, provided the reporting person remains employed through each vesting date. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/19/2025.

Insights

Financial Analyst

TL;DR: Routine equity-based compensation grant to a senior HR officer; not a market-moving event.

The 2,152 RSU award is a standard, non-cash compensation mechanism that aligns the executive with shareholder interests by delivering shares subject to multi-year vesting. The grant price reported as $0 reflects a compensation grant rather than an open-market purchase. Vesting over three annual installments introduces retention incentives but creates only a modest potential dilution relative to total outstanding shares (dilution percentage not provided in the filing). No sale or open-market transaction was reported here.

Corporate Governance Expert

TL;DR: Governance-wise this is a standard officer RSU award with time-based vesting and routine disclosure.

The Form 4 discloses a time-based award to a named officer, consistent with typical compensation practices. The filing includes vesting schedule details which support transparency about the conditions under which shares will be issued. There is no indication of performance-based acceleration or special vesting events in the disclosure, and the form was executed by an attorney-in-fact as permitted by Form 4 rules.

Insider Trade Summary

Net Buyer: 2,152 shares

Net Buy 1 txn

Insider Escudero Lisa Ann

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	2,152	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 2,152 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 08/19/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Escudero Lisa Ann

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/15/2025		A		2,152(2)	A	$0	2,152	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Remarks:

Senior Vice President, Human Resources. Exhibit List - Exhibit 24.1 Power of Attorney

	/s/ Judith Weinstein, as Attorney-in-Fact for Lisa Ann Escudero	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.